LORIE COLLIER: Open Payments
NPI 1578803219 · WASHINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 39 payments from 12 companies in 2025. Trend: 2023 $645 · 2024 $624 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 10 | $172 |
| Calliditas Therapeutics US Inc. | 6 | $165 |
| Mallinckrodt Hospital Products Inc. | 7 | $149 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Novo Nordisk Inc | 2 | $48 |
| AKEBIA THERAPEUTICS INC | 2 | $39 |
| Apellis Pharmaceuticals, Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Travere Therapeutics, Inc. | 1 | $25 |
Products named: VELPHORO, TARPEYO, ACTHAR, JYNARQUE, Vafseo, Empaveli, Kerendia, AREXVY.
Industry payments across NC — which companies pay providers there.
